Actemra (Tocilizumab) injection is used to treat Rheumatoid Arthritis (RA).

ACTEMRA® (tocilizumab) is an interleukin-6 (IL-6) receptor antagonist indicated for treatment of Rheumatoid Arthritis (RA), Giant Cell Arteritis (GCA) , Polyarticular Juvenile Idiopathic Arthritis (PJIA), Systemic Juvenile Idiopathic Arthritis (SJIA), Cytokine Release Syndrome (CRS)

Tocilizumab, also known as atlizumab, is an immunosuppressive drug, mainly for the treatment of rheumatoid arthritis (RA) and systemic juvenile idiopathic arthritis, a severe form of arthritis in children. It is a humanized monoclonal antibody against the interleukin-6 receptor (IL-6R). Interleukin 6 (IL-6) is a cytokine that plays an important role in immune response and is implicated in the pathogenesis of many diseases, such as autoimmune diseases, multiple myeloma and prostate cancer.

Intravenous Infusion Injection: 80 mg/4 mL (20 mg/mL), 200 mg/10 mL (20 mg/mL), 400 mg/20 mL (20 mg/mL) in single-dose vials for further dilution prior to intravenous infusion

Subcutaneous Injection Injection: 162 mg/0.9 mL in a single-dose prefilled syringe

Actemra (Tocilizumab) injection suppliers in India

IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.

For procurement cost of Actemra (Tocilizumab) injection brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 / 9891296838 or Email Us to know more details about the medicine and its cost price in India.

The order for Actemra (Tocilizumab) injection will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

Actemra (Tocilizumab injection)

Actemra (Tocilizumab injection) for injection is available.

Get In Touch

Facilitator under Named Patient Supply.

Head Office of Indian Pharma Network (IPN) is in New Delhi, INDIA. Indian Pharma Network (IPN) act as a facilitator for you, under Named Patient Supply for anti-cancer medicines.

For overseas patient " Actemra (Tocilizumab) injection " brands can be also made available to overseas patients, doctors and hospitals at China, Cambodia, Indonesia, Nepal, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand. The order will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

News / Update for Actemra (Tocilizumab) .

For Actemra (Tocilizumab) injection Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details

Half of GCA patients receiving tocilizumab remained in remission 2 years after withdrawal For More Details

CAR-T Cell Therapy For More Details

Channel Partner In India

Delhi Office

60/4, T&T House. Yusuf Sarai,
New Delhi:110016

Bangalore Office

#308, Raheja Chambers, 12,
Museum Road, Bangalore 560 001

Kolkata Office

1/A R.G Kar Road, Shayambazar,
Kolkata 700004

Lucknow Office

203-A, 2nd Floor, Tower -11, Felix
Square, IBB-2, Sushant Golf city, Lucknow 226030